Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

Medicine Matters oncology

Amsterdam, Netherlands

Erik Thunnissen is consultant pathologist and staff member in the Department of Pathology, VUmc, Amsterdam a focus on Pulmonary Pathology. He is a long standing member of the IASLC pathology committee, leading reproducibility studies of the WHO classification for lung cancer and has taken responsibility for pulmonary molecular external quality assessment (EQA) programs in the Netherlands and for the European Society of Pathology.